Page last updated: 2024-09-03

imatinib mesylate and Cancer of Endometrium

imatinib mesylate has been researched along with Cancer of Endometrium in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bono, Y; Fujiwara, H; Kyo, S; Maida, Y; Mizumoto, Y; Nakamura, M; Takakura, M; Zhang, X1
Agorastos, T; Bontis, J; Theodoridis, TD; Venizelos, ID; Zafrakas, M; Zepiridis, L1
Cho, JH; Hur, M; Kim, WS; Ko, YS; Lee, MH; Moon, HW; Yun, YM1
Broaddus, RR; Burke, TW; Gershenson, DM; Lu, KH; Oh, JC; Ramondetta, LM; Schmandt, R; Slomovitz, BM; Wu, W1
Ban, S; Fujimura, M; Hirose, T; Ishihara, O; Mitsuhashi, T; Nakayama, M; Ogawa, F; Sakurai, S; Shimizu, M; Shimizu, Y1
Bauerschlag, DO; Hilpert, F; Jonat, W; Maass, N; Meinhold-Heerlein, I; Mundhenke, C; Roesel, F; Schem, C; Sturner, KH; Weigel, MT1

Reviews

2 review(s) available for imatinib mesylate and Cancer of Endometrium

ArticleYear
KIT protein expression in uterine sarcomas: an immunohistochemical study and review of the literature.
    European journal of gynaecological oncology, 2008, Volume: 29, Issue:3

    Topics: Benzamides; Endometrial Neoplasms; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Leiomyosarcoma; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma, Endometrial Stromal

2008
Therapy-related acute leukemia with mixed phenotype and t(9;22)(q32;q11.2): a case report and review of the literature.
    Human pathology, 2012, Volume: 43, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Back; Benzamides; Bone Marrow; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Cytarabine; Endometrial Neoplasms; Female; Gene Rearrangement; Genes, abl; Humans; Idarubicin; Imatinib Mesylate; Immunophenotyping; Induction Chemotherapy; Karyotyping; Leukemia, Myeloid, Acute; Leukemic Infiltration; Middle Aged; Neoplasms, Second Primary; Piperazines; Pyrimidines; Remission Induction; Soft Tissue Neoplasms; Submandibular Gland Neoplasms; Translocation, Genetic

2012

Other Studies

4 other study(ies) available for imatinib mesylate and Cancer of Endometrium

ArticleYear
Imatinib sensitizes endometrial cancer cells to cisplatin by targeting CD117-positive growth-competent cells.
    Cancer letters, 2014, Apr-01, Volume: 345, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Synergism; Endometrial Neoplasms; Female; Humans; Imatinib Mesylate; Mice; Mice, Inbred BALB C; Middle Aged; Molecular Targeted Therapy; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Random Allocation; Xenograft Model Antitumor Assays

2014
Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.
    Gynecologic oncology, 2004, Volume: 95, Issue:1

    Topics: Antineoplastic Agents; Benzamides; Carcinoma, Endometrioid; Endometrial Neoplasms; Enzyme Inhibitors; Female; Humans; Imatinib Mesylate; Immunohistochemistry; Paraffin Embedding; Phosphorylation; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptors, Platelet-Derived Growth Factor

2004
KIT-negative undifferentiated endometrial sarcoma with the amplified epidermal growth factor receptor gene showing a temporary response to imatinib mesylate.
    Annals of diagnostic pathology, 2007, Volume: 11, Issue:1

    Topics: Antineoplastic Agents; Benzamides; Biopsy; Cell Differentiation; DNA, Neoplasm; Endometrial Neoplasms; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Sarcoma

2007
Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects.
    Journal of cancer research and clinical oncology, 2008, Volume: 134, Issue:12

    Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Carboplatin; Carcinoma, Papillary; Cell Proliferation; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Humans; Imatinib Mesylate; Immunoenzyme Techniques; Ovarian Neoplasms; Paclitaxel; Piperazines; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; RNA, Messenger; RNA, Neoplasm; Tissue Array Analysis; Tumor Cells, Cultured

2008